About StrionAir

StrionAir, Inc. bridges the traditional gap between healthy air and energy costs - erasing the tradeoff requiring higher power consumption to get cleaner air. And StrionAir filters possess a unique germicidal effect - destroying trapped microorganisms to make filtration an active part of a healthy facility. StrionAir manufactures and markets this patented, breakthrough air-filtration technology that renders existing air-filtration solutions technically inferior and cost ineffective. Based on pioneering research performed by Lawrence Livermore National Lab and commercialized by StrionAir's founders over the past ten years, StrionAir has created the industry's first germicidal, high efficiency, low pressure air filtration system.

StrionAir's System provides a compelling ROI that enables facilities managers to reduce operating costs, protect building occupants from airborne pathogens and pollutants and provide a more comfortable, productive work environment. The technology delivers additional benefits to facility owners and managers concerned with proactively addressing today's most important and litigious indoor air quality challenges including: biological- and radiological-related terrorist threats, sick building syndrome and nosocomial (hospital-acquired) infections.